Literature DB >> 8212819

Evaluation of different immunization schedules for oral cholera B subunit-whole cell vaccine in Swedish volunteers.

M Jertborn1, A M Svennerholm, J Holmgren.   

Abstract

Different immunization schedules for oral B subunit-whole cell (B-WC) cholera vaccine were evaluated in Swedish volunteers to obtain information for recommendations of vaccine use in non-endemic areas. Two peroral doses of B-WC vaccine were as effective as three doses in inducing IgA and IgG antitoxin as well as vibriocidal antibody responses in serum. Administration of two vaccine doses either at 7, 14 or 28-42 day intervals resulted in comparable antitoxin responses in serum, whereas a 3-day immunization interval resulted in significantly lower titre increases. Vibriocidal antibody responses were comparable after the different time intervals tested (3-42 days). The B-WC vaccine can be effectively administered together with a cheap, commercially available sodium bicarbonate powder dissolved in water to protect the vaccine from gastric acid.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8212819     DOI: 10.1016/0264-410x(93)90125-h

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  14 in total

1.  Anatomic segmentation of the intestinal immune response in nonhuman primates: differential distribution of B cells after oral and rectal immunizations to sites defined by their source of vascularization.

Authors:  K Eriksson; M Quiding-Järbrink; J Osek; I Nordström; M Hjulström; J Holmgren; C Czerkinsky
Journal:  Infect Immun       Date:  1999-11       Impact factor: 3.441

2.  Immune responses in ileostomy fluid and serum after oral cholera vaccination of patients colectomized because of ulcerative colitis.

Authors:  J Kilhamn; H Brevinge; A M Svennerholm; M Jertborn
Journal:  Infect Immun       Date:  1998-08       Impact factor: 3.441

3.  Specific-antibody-secreting cells in the rectums and genital tracts of nonhuman primates following vaccination.

Authors:  K Eriksson; M Quiding-Järbrink; J Osek; A Möller; S Björk; J Holmgren; C Czerkinsky
Journal:  Infect Immun       Date:  1998-12       Impact factor: 3.441

4.  Kinetics of local and systemic immune responses to an oral cholera vaccine given alone or together with acetylcysteine.

Authors:  J Kilhamn; M Jertborn; A M Svennerholm
Journal:  Clin Diagn Lab Immunol       Date:  1998-03

5.  Comparison of the oral, rectal, and vaginal immunization routes for induction of antibodies in rectal and genital tract secretions of women.

Authors:  P A Kozlowski; S Cu-Uvin; M R Neutra; T P Flanigan
Journal:  Infect Immun       Date:  1997-04       Impact factor: 3.441

6.  Intranasal vaccination of humans with recombinant cholera toxin B subunit induces systemic and local antibody responses in the upper respiratory tract and the vagina.

Authors:  C Bergquist; E L Johansson; T Lagergård; J Holmgren; A Rudin
Journal:  Infect Immun       Date:  1997-07       Impact factor: 3.441

7.  Immunization with Vibrio cholerae outer membrane vesicles induces protective immunity in mice.

Authors:  Stefan Schild; Eric J Nelson; Andrew Camilli
Journal:  Infect Immun       Date:  2008-08-04       Impact factor: 3.441

8.  Intestinal and systemic immune responses to an oral cholera toxoid B subunit whole-cell vaccine administered during zinc supplementation.

Authors:  Tom H Karlsen; Halvor Sommerfelt; Skjalg Klomstad; Per Kragh Andersen; Tor A Strand; Rune J Ulvik; Christina Ahrén; Harleen M S Grewal
Journal:  Infect Immun       Date:  2003-07       Impact factor: 3.441

9.  Lipopolysaccharide modifications of a cholera vaccine candidate based on outer membrane vesicles reduce endotoxicity and reveal the major protective antigen.

Authors:  Deborah R Leitner; Sandra Feichter; Kristina Schild-Prüfert; Gerald N Rechberger; Joachim Reidl; Stefan Schild
Journal:  Infect Immun       Date:  2013-04-29       Impact factor: 3.441

10.  Use of oral cholera vaccine in complex emergencies: what next? Summary report of an expert meeting and recommendations of WHO.

Authors:  Claire-Lise Chaignat; Victoria Monti
Journal:  J Health Popul Nutr       Date:  2007-06       Impact factor: 2.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.